Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx Pills
mSMART
Mobile Application Based Personalized Solutions and Tools for Medication Adherence of Rx Pills
2 other identifiers
observational
11
1 country
1
Brief Summary
The primary aim of this study is to conduct a 9-patient feasibility and acceptability study of mSMART (with future studies focusing on improved medication adherence). The sample will include daily smokers who are already taking a prescribed medication. There will be no change in any medication regimen in this study, and the sample will include smokers either with or without a psychiatric disorder. Subjects will be asked to use a smartphone application, or "app" (i.e. mSMART) that will provide information about their medication and when to take it. Along with smart phone, the participants will be asked to utilize an electronic pillbox (i.e. GlowCap) to further assist with medication compliance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 21, 2014
CompletedFirst Posted
Study publicly available on registry
February 26, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedJuly 31, 2014
July 1, 2014
2 months
February 21, 2014
July 29, 2014
Conditions
Outcome Measures
Primary Outcomes (2)
Percentage of alarms emitted by msmart app that subjects respond to.
Measurement of app feasibility.
7 days
Likert response score
Likert scale responses to a questionnaire completed at follow-up visit. Questionnaire asks for agreement with statements relating to acceptability of the app. Scale: 1. = not at all 2. = somewhat 3. = moderately 4. = extremely (example question: What was your overall satisfaction with mSMART?)
After 7 day observation period.
Secondary Outcomes (1)
Percentage of study participant attrition.
7 days
Study Arms (1)
Regular cigarette smokers
Interventions
This application is an interface that provides subjects with information and questionnaires related to their medication.
Eligibility Criteria
Participants will be 15 adult, nicotine dependent smokers for a target completion sample of 9. Subjects will be allowed to meet criteria for a current comorbid psychiatric disorder (e.g., Attention-Deficit/Hyperactivity Disorder \[ADHD\], Post-Traumatic Stress Disorder, Major Depressive Disorder), though non-psychiatric smokers will be included as well. Participants will be taking some form of prescribed psychiatric medication or nicotine replacement therapy in pill form.
You may qualify if:
- years of age
- Male or female
- Taking a prescribed psychiatric or smoking cessation medication in pill form over the past 30 days
- Self-report smoking at least 5 cigarettes/day
- Provides an afternoon exhaled carbon monoxide reading of at least 5 ppm.
- Cognitive functioning \> 80 as assessed by the Kaufmann Brief Intelligence Test, second edition (KBIT-II)
You may not qualify if:
- Significant and chronic medical problems
- Estimated IQ \< 80 on Kaufmann Brief Intelligence Test, Second Edition
- Meets criteria for any other Axis I Disorder (determined by the Structured Diagnostic Interview for DSM; SCID) that requires intervention and might interfere with study participation
- Current non-nicotine substance abuse or dependence or history within the last 3 months
- Females who are pregnant or attempting to become pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Intelligent Automation, Inc.collaborator
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27705, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John T Mitchell, Ph.D.
Duke University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2014
First Posted
February 26, 2014
Study Start
February 1, 2014
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
July 31, 2014
Record last verified: 2014-07